City

Detroit (1)

Condition

Blood and Lymphatic Diseases (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

Sponsor

Sangamo Therapeutics (1)

Collaborator

Intervention

bivv003 (1)

st-400 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Observational (1)

blood and lymphatic diseases

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

Recruiting

Blood and Lymphatic Diseases

Detroit, Michigan

Investigational Site Number :8400001

Jul 6, 2022